Evidence map›Paper›PMID 20142257›Full record

ReviewCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).

Linda Patrick-Miller, Angela R Bradbury, Mary Beth Terry

Abstract readReview
In one paragraph

Review in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Linda Patrick-MillerThe Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA. patmiller@umdnj.edu
Angela R Bradbury
Mary Beth Terry

Funding

Returning genetic research panel results for breast cancer susceptibilityR01CA190871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2014 to 2025
$6.7M
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family RegistryR01CA138819 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI BRADBURY, ANGELA R., DALY, MARY BERYL · 2011 to 2015
$3.3M
Communicating Genetic Test Results by Telephone: A Randomized TrialR01CA160847 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2012 to 2015
$2.5M
Virtual Cancer Genetic Services: Telemedicine Delivery in Community ClinicsR21CA164121 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2012 to 2013
$400k
NCI NIH HHS L30 CA130130NCI NIH HHS R01 CA138819NCI NIH HHS R01 CA160847NCI NIH HHS R01 CA190871NCI NIH HHS R21 CA164121
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultChildGenetic Predisposition to DiseaseGenetic TestingHumansTruth Disclosure

Identifiers

PMID20142257
PMCPMC4199582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.